Online inquiry

IVTScrip™ mRNA-Human CD156b, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A))   (CAT#: GTTS-WK3380MR)

This product GTTS-WK3380MR is a type of mRNA having 30 nt poly(A) tail and modified with Cap 0 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the CD156b protein. This product can be used in -related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 0
Species Human
RefSeq NM_003183
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification oligo-dT affinity purification
Target Gene
Gene ID 6868
UniProt ID P78536
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human CD156b, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) (GTTS-WK3380MR). Click the button above to contact us or submit your feedback about this product.
See other products
CAT Product Name Product Type CDs
GTTS-WK12525MR IVTScrip™ mRNA-Human ADCYAP1, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ADCYAP1
GTTS-WK0380MR IVTScrip™ mRNA-Human CD156b, (Cap 0, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA CD156b
GTTS-WK7749MR IVTScrip™ mRNA-Human ADH5, (Cap 0, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA ADH5
GTTS-WK12563MR IVTScrip™ mRNA-Human ADPGK, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ADPGK
GTTS-WK3215MR IVTScrip™ mRNA-Human PKC-alpha, (Cap 0, 5-Methyl-CTP, 30 nt-poly(A)) mRNA PKC-alpha
GTTS-WK14872MR IVTScrip™ mRNA-Human ANAPC5, (Cap 0, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA ANAPC5
GTTS-WK28458MR IVTScrip™ mRNA-Human ATG3, (Cap 1, 5-Methyl-CTP, 30 nt-poly(A)) mRNA ATG3
GTTS-WK9851MR IVTScrip™ mRNA-Human ADHFE1, (Cap 0, 5-Methoxy-UTP, 30 nt-poly(A)) mRNA ADHFE1
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
×

Webinar Register

Simone Pinto Carneiro, Ph.D.

Group Leader, Ludwig-Maximilians-University of Munich

date-time 10AM EDT | May 19, 2026

Register Now →